A somewhat controversial review, which suggests that COX-2 inhibitors may be preferential to regular NSAIDs in patients at risk of cardiovascular events taking low-dose aspirin, has been published. But many experts are not so sure about its conclusions. Heartwire
The post hoc finding, which was relative to placebo, is unusual for an antiarrhythmic agent. The investigational drug is envisioned as a potentially safer alternative to amiodarone. Heartwire
A new Italian study has shown, for the first time, that consuming moderate amounts of dark chocolate can significantly reduce C-reactive protein levels. Medscape Medical News
Investigators caution that the data are preliminary, but the 30-day risk of stroke and death observed in clinical trials is lower when more experienced operators perform the procedure. Heartwire
